Security Snapshot

GSK plc - SPONSORED ADR (GSK) Institutional Ownership

CUSIP: 37733W204

13F Institutional Holders and Ownership History from Q1 2016 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

979

Shares (Excl. Options)

397,642,001

Price

$49.04

Type / Class
Equity / SPONSORED ADR
Symbol
GSK on NYSE
Price per share
$55.19
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
397,642,001
Total reported value
$19,502,567,832
% of total 13F portfolios
0.02%
Share change
+11,026,823
Value change
+$561,188,548
Number of holders
979
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Sponsored

Quick Takeaways

  • GSK - GSK plc - SPONSORED ADR is tracked under CUSIP 37733W204.
  • 979 institutions reported positions in Q4 2025.
  • Schedule 13D/13G significant owner rows are not currently available.

What Changed

  • Holder count moved from 979 to 70 between Q4 2025 and Q1 2026.
  • Reported value moved from $19,502,567,832 to $69,963,990.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Official SEC Source

Backed by Form 13F

Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.

See Original Filing

Investment Quick Answers

What is CUSIP 37733W204?
CUSIP 37733W204 identifies GSK - GSK plc - SPONSORED ADR in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

As of 31 Dec 2025, 979 institutional investors reported holding 397,642,001 shares of GSK plc - SPONSORED ADR (GSK).

Institutional Holders of GSK plc - SPONSORED ADR (GSK) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 1,266,785 $69,963,990 -$11,511,675 $55.19 70
2025 Q4 397,642,001 $19,502,567,832 +$561,188,548 $49.04 979
2025 Q3 385,810,445 $16,653,456,346 +$149,628,861 $43.16 883
2025 Q2 377,323,511 $14,492,600,704 +$691,641,935 $38.40 873
2025 Q1 365,061,086 $14,138,125,686 +$1,006,993,911 $38.74 839
2024 Q4 340,917,752 $11,541,588,389 +$1,180,300,325 $33.82 833
2024 Q3 302,968,498 $12,377,977,607 -$140,106,119 $40.88 883
2024 Q2 309,126,756 $11,909,339,872 -$23,346,819 $38.50 869
2024 Q1 308,583,941 $13,222,947,461 +$833,173,631 $42.87 891
2023 Q4 289,484,844 $10,732,131,887 +$174,194,109 $37.06 882
2023 Q3 284,245,298 $10,307,406,122 +$264,432,361 $36.25 835
2023 Q2 276,495,626 $9,857,311,052 +$194,467,459 $35.64 814
2023 Q1 269,710,676 $9,600,329,935 -$208,079,525 $35.58 792
2022 Q4 276,203,256 $9,708,565,984 +$516,369,806 $35.14 788
2022 Q3 264,324,002 $7,785,299,734 +$7,652,922,694 $29.43 697
2022 Q2 4,250,301 $185,367,037 +$183,087,502 $43.53 67
2022 Q1 52,302 $2,281,067 -$356,058 $43.56 7
2021 Q4 60,336 $2,667,168 -$139,973 $44.10 7
2021 Q3 17,405 $671,931 +$7,790 $38.21 6
2021 Q2 17,188 $691,875 -$30,222 $39.82 6
2021 Q1 17,949 $649,577 +$393,265 $35.69 6
2020 Q4 7,178 $264,151 -$29,072 $36.80 4
2020 Q3 7,968 $299,261 +$325 $37.64 4
2020 Q2 7,971 $325,296 -$17,284 $40.79 3
2020 Q1 8,394 $316,305 -$7,502 $37.89 3
2019 Q4 8,592 $403,759 +$47 $46.99 3
2019 Q3 6,012 $256,603 +$43 $42.68 2
2019 Q2 6,011 $240,560 +$280 $40.02 2
2019 Q1 6,004 $250,926 -$58,469 $41.79 2
2018 Q4 7,403 $282,874 -$23,957 $38.21 2
2018 Q3 8,030 $322,558 -$357,464 $40.17 2
2018 Q2 16,929 $682,392 +$81 $40.31 2
2018 Q1 16,927 $661,338 +$10,158 $39.07 2
2017 Q4 16,667 $591,179 -$47,282 $35.47 2
2017 Q3 18,000 $730,800 -$109,620 $40.60 2
2017 Q2 20,700 $892,584 $43.12 2
2017 Q1 20,700 $872,712 $42.16 2
2016 Q4 20,700 $797,157 +$182,191 $38.51 2
2016 Q3 15,969 $688,743 +$10,783 $43.13 2
2016 Q2 15,719 $681,261 -$56,342 $43.34 2
2016 Q1 17,019 $690,120 $40.55 2

Sponsored